ProShares S&P Kensho Cleantech ETF (CTEX) Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CTEX Stock Alerts $20.66 +0.68 (+3.40%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings ProShares S&P Kensho Cleantech ETF Stock Price Performance5 Day Performance+3.28%1 Month Performance-11.31%3 Month Performance-9.88%6 Month Performance-0.12%Year-To-Date Performance-23.78%1 Year Performance-33.73% Receive CTEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ProShares S&P Kensho Cleantech ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> CTEX Stock Chart for Saturday, April, 27, 2024 CTEX Chart by TradingView ProShares S&P Kensho Cleantech ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$19.98$20.66+3.41%$20.66$20.668 shs$3.10 million04/25/2024$20.27$19.98-1.45%$19.98$19.983 shs$3.00 million04/24/2024$20.44$20.27-0.82%$20.27$20.2751 shs$3.04 million04/23/2024$20.00$20.44+2.20%$20.44$19.89125 shs$3.07 million04/22/2024$19.99$20.00+0.07%$20.00$20.0074 shs$3 million04/19/2024$20.19$19.80-1.93%$19.96$19.80547 shs$2.97 million Get the Latest News and Ratings for CTEX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares S&P Kensho Cleantech ETF and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$20.56$20.19-1.80%$20.19$20.19164 shs$3.03 million04/17/2024$20.54$20.56+0.10%$20.56$20.56136 shs$4.11 million04/16/2024$20.86$20.54-1.53%$20.54$20.54113 shs$4.11 million04/15/2024$21.56$20.86-3.25%$20.86$20.8660 shs$4.17 million04/12/2024$22.35$21.56-3.53%$21.56$21.5632 shs$4.31 million04/11/2024$22.44$22.35-0.40%$22.35$22.3561 shs$4.47 million04/10/2024$23.19$22.44-3.23%$22.44$22.31286 shs$4.49 million04/09/2024$22.61$23.19+2.57%$23.19$22.832,630 shs$4.64 million04/08/2024$22.48$22.61+0.60%$22.61$22.6122 shs$4.52 million04/05/2024$22.67$22.48-0.84%$22.57$22.48289 shs$4.50 million04/04/2024$22.79$22.67-0.53%$23.15$22.672,381 shs$4.53 million04/03/2024$22.59$22.79+0.89%$22.79$22.7992 shs$4.56 million04/02/2024$23.40$22.59-3.45%$22.59$22.5912 shs$4.52 million04/01/2024$23.41$23.40-0.06%$23.59$23.40515 shs$4.68 million03/29/2024$23.41$23.41$23.41$23.4190 shs$4.68 million03/28/2024$23.29$23.41+0.52%$23.41$23.4190 shs$4.68 million03/27/2024$22.19$23.29+4.96%$23.29$23.2927 shs$4.66 million03/26/2024$22.30$22.19-0.49%$22.20$22.19175 shs$4.44 million03/25/2024$22.49$22.30-0.84%$22.30$22.3023 shs$4.46 million03/22/2024$22.98$22.49-2.13%$22.88$22.49736 shs$4.50 million03/21/2024$22.63$22.98+1.55%$22.98$22.98143 shs$4.60 million03/20/2024$21.96$22.63+3.03%$22.63$22.63112 shs$4.53 million03/19/2024$21.95$21.96+0.07%$22.04$21.96371 shs$4.39 million03/18/2024$21.94$21.95+0.07%$21.95$21.9514 shs$4.39 million03/15/2024$21.70$21.94+1.11%$21.94$21.9412 shs$4.39 million03/14/2024$22.39$21.70-3.08%$21.70$21.60307 shs$4.34 million03/13/2024$22.87$22.39-2.10%$22.39$22.39157 shs$4.48 million03/12/2024$23.30$22.87-1.85%$22.87$22.74689 shs$4.57 million03/11/2024$23.73$23.30-1.79%$23.30$23.3091 shs$4.66 million03/08/2024$23.48$23.73+1.04%$23.73$23.7379 shs$4.75 million03/07/2024$23.30$23.48+0.77%$23.48$23.4877 shs$4.70 million03/06/2024$22.85$23.30+1.97%$23.30$23.27264 shs$4.66 million03/05/2024$23.29$22.85-1.89%$22.85$22.8582 shs$4.57 million03/04/2024$23.43$23.29-0.58%$23.29$23.2960 shs$4.66 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$22.97$23.43+2.00%$23.43$22.92337 shs$4.69 million02/29/2024$23.06$22.97-0.39%$22.97$22.97121 shs$4.59 million02/28/2024$23.27$23.06-0.90%$23.06$23.06141 shs$4.61 million02/27/2024$22.81$23.27+2.02%$23.27$22.8610,820 shs$4.65 million02/26/2024$22.68$22.81+0.59%$22.81$22.817 shs$4.56 million02/23/2024$22.78$22.60-0.79%$22.60$22.60109 shs$4.52 million02/22/2024$23.65$22.78-3.68%$22.78$22.7852 shs$4.56 million02/21/2024$24.10$23.65-1.87%$23.65$23.48201 shs$4.73 million02/20/2024$24.86$24.10-3.06%$24.10$24.1044 shs$4.82 million02/19/2024$24.86$24.860.00%$24.86$24.86100 shs$4.97 million02/16/2024$25.49$24.86-2.47%$24.86$24.8690 shs$4.97 million02/15/2024$25.18$25.49+1.23%$25.55$25.49119 shs$5.10 million02/14/2024$23.93$25.18+5.22%$25.18$25.1818 shs$5.04 million02/13/2024$25.67$23.93-6.78%$24.55$23.771,463 shs$4.79 million02/12/2024$24.53$25.67+4.67%$25.67$25.52623 shs$5.13 million02/09/2024$23.78$24.52+3.11%$24.52$23.84143 shs$4.90 million02/08/2024$23.51$23.78+1.15%$23.78$23.7815 shs$4.76 million02/07/2024$22.90$23.51+2.66%$23.51$23.5140 shs$4.70 million02/06/2024$22.43$22.90+2.10%$22.90$22.9067 shs$4.58 million02/05/2024$23.33$22.43-3.86%$22.43$22.21494 shs$4.49 million02/02/2024$23.69$23.33-1.52%$23.35$23.15818 shs$4.67 million02/01/2024$22.69$23.69+4.41%$23.69$23.6945 shs$4.74 million01/31/2024$23.16$22.69-2.03%$23.61$22.69183 shs$4.54 million01/30/2024$23.46$23.16-1.28%$23.29$23.161,298 shs$4.63 million01/29/2024$22.92$23.46+2.36%$23.46$22.50229 shs$4.69 million01/26/2024$23.08$22.92-0.69%$22.92$22.925 shs$4.58 million Related Companies: Hypatia Women CEO ETF Stock Price Chart BlackRock Future Climate and Sustainable Economy ETF Stock Price Chart Roundhill MEME ETF Stock Price Chart Global X PropTech ETF Stock Price Chart iShares Virtual Work and Life Multisector ETF Stock Price Chart AdvisorShares Restaurant ETF Stock Price Chart Newday Ocean Health ETF Stock Price Chart Jacob Forward ETF Stock Price Chart ProShares Ultra Nasdaq Cloud Computing ETF Stock Price Chart iShares Breakthrough Environmental Solutions ETF Stock Price Chart Receive CTEX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares S&P Kensho Cleantech ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:CTEX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares S&P Kensho Cleantech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.